NCT06452277 2026-04-17
SOHO-02
Bayer
Phase 3 Recruiting
Clinical Trials
3 trialsNCT06868732 2026-03-30
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Recruiting
NCT04699123 2025-05-13
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
Yale University
Phase 2 Active not recruiting